TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01606488

Intervention type: DRUG
Group type: OTHER
Intervention: Florbetapir F 18 (18F-AV-45)
Description: Single IV bolus injection of 370 MBq (10mCi) florbetapir will be administered approximately 50 minutes prior to a 10 minute PET scan.

Intervention type: OTHER
Group type: OTHER
Intervention: no intervention
Study: NCT01247103

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to match AZD4316
Study: NCT00913627

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ibuprofen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ibuprofen

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: naproxen

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT03856580

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Alternative long-acting PrEP injection strategies
Description: Participants in the two intervention groups will complete injection procedures (e.g., self-injection, injection by healthcare providers at drop-in clinics) to determine if this could facilitate improved adherence to an inert version of long-acting cabotegravir injections

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Alternative long-acting PrEP injection strategies
Description: Participants in the two intervention groups will complete injection procedures (e.g., self-injection, injection by healthcare providers at drop-in clinics) to determine if this could facilitate improved adherence to an inert version of long-acting cabotegravir injections

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth adherence app
Description: Participants in the two experimental arms will be given a smartphone application, designed to facilitate adherence (this app will be developed during earlier phases of the study using in-depth interviews and design session groups)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth adherence app
Description: Participants in the two experimental arms will be given a smartphone application, designed to facilitate adherence (this app will be developed during earlier phases of the study using in-depth interviews and design session groups)
Study: NCT03830970

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Canned beans of multiple varieties
Description: Daily rotation of different varieties of canned beans including black, navy, pinto, red kidney and white kidney

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Canned beans of multiple varieties
Description: Daily rotation of different varieties of canned beans including black, navy, pinto, red kidney and white kidney

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: White Rice
Description: Minute Rice Long Grain White Rice
Study: NCT00700089

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Assertive intervention
Description: 8-20 assertive contacts after suicide attempt

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard treatment
Description: In standard treatment there is no procedure for ensuring that the patient will actually receive the recommended treatment. Patients are often referred to available treatment modalities such as general practitioner, psychological treatment, treatment for alcohol abuse, and most often, the patients are themselves responsible for getting into contact with the treatment to which they are referred.
Study: NCT02285309

Intervention type: PROCEDURE
Intervention: Cardiac Surgery and enoximone
Description: Does diastolic function change with cardiac surgery +/- enoximone
Study: NCT00826293

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stabilization belt
Description: Patients receive true stabilization.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Stabilization belt
Description: Patients receive sham stabilization.
Study: NCT04313439

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online cognitive therapy (I-CT)
Description: The treatment is an online cognitive therapy consisting of a structured self-help program over ten weeks, divided into eight modules, administered in an encrypted web platform. The program is based on the treatment manual The treatment of Obsessions by Stanley Rachman. In this treatment, the participant is recommended to perform daily exercises in order to identify and modify interpretations made about the importance of their obsessive thoughts. A designated therapist have email contact with the participant within the encrypted platform.
Study: NCT03193307

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Microgynon® 30
Description: Run in period \& Treatment Period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 409306
Description: Day 18 \& 29 (Treatment Period)
Study: NCT04462250

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Prescription Opioid Management App
Description: Smartphone application that provides education and reinforcement of safe opioid use, storage, and disposal

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Prescription Opioid Management App
Description: Smartphone application that provides education and reinforcement of safe opioid use, storage, and disposal

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Prescription Opioid Management App
Description: Smartphone application that provides education and reinforcement of safe opioid use, storage, and disposal
Study: NCT04264221

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: New management mode
Description: * New management mode intervention: Pharmaceutical care~* SMS text messages and Phone Calls~* Behavioural Educational leaflet~* Self-Administered Therapy A financial incentive for mobile use
Study: NCT03942770

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Contingency Management
Description: Monetary incentives are delivered to participants contingent upon on-time breathalyzer submissions and verified abstinence from alcohol.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Contingency Management
Description: Monetary incentives are delivered to participants contingent upon on-time breathalyzer submissions and verified abstinence from alcohol.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Contingency management
Description: Monetary incentives are delivered to participants contingent upon on-time breathalyzer submissions only with no contingency on alcohol use.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Contingency management
Description: Monetary incentives are delivered to participants contingent upon on-time breathalyzer submissions only with no contingency on alcohol use.
Study: NCT02113722

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Left cardiac sympathetic denervation
Description: Left cardiac sympathetic denervation via a video
Study: NCT04433143

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minocycline hydrochloride capsules were taken orally
Description: Lumenis OneTM, OPT tender system produced by American Medical Science Company; Use four of the filters. Acne filter has a wavelength of 400-600/800-1200nm. Three pulses were used for treatment, with a pulse width of 5.0ms, a pulse delay of 30ns, and an energy density of 15j /cm2. The instrument parameters were selected according to the skin lesion characteristics, age and tolerance.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minocycline hydrochloride capsules were taken orally
Description: Lumenis OneTM, OPT tender system produced by American Medical Science Company; Use four of the filters. Acne filter has a wavelength of 400-600/800-1200nm. Three pulses were used for treatment, with a pulse width of 5.0ms, a pulse delay of 30ns, and an energy density of 15j /cm2. The instrument parameters were selected according to the skin lesion characteristics, age and tolerance.
Study: NCT00761124

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Session
Description: A one-hour discussion group composed of 8-10 Latino men. The session includes an interactive, multimedia presentation led by a facilitator to guide participant interaction.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Printed Material
Description: General prostate cancer pamphlet
Study: NCT01910506

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RDEA3170 10 mg
Study: NCT03227861

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DRV 800 mg + COBI 150 mg + FTC 200 mg + TAF 10 mg FDC
Description: Participants will receive oral tablet containing D 800 mg /C 150 mg /F 200 mg /TAF 10 mg FDC once daily within 24 hours of the screening/ baseline visit.
Study: NCT02758145

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Flu vaccination information in 3 phases
Description: An oral information is given by the nurse during the recruitment visit at the occupational medicine unit. She initiates the discussion on flu and asks the employee if he usually receives the vaccine. Then she provides a brief standardized information on recommendations concerning flu vaccination, and the annual influenza vaccination campaign in CHUV and PMU. She responds to questions.~After the interview, she gives an informative document with key messages (information about the disease, benefits to be vaccinated, vaccine safety, etc.). The document includes frequently asked questions, website address, and the email address of the occupational medicine unit in case of questions.~The third phase consists of sending to the employee shortly after the start of the next campaign of flu vaccination (November 2016), a postal mail recalling the information provided during the recruitment examination and inviting them to get vaccinated.
Study: NCT02325999

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ESD AND LRLD
Description: A new therapy for gastric cancer : Endoscopic Submucosal Dissection combine with Laparoscopic Regional Lymph node Dissection.
Study: NCT01160367

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TAILORED Patient Family Decision Making
Description: Patient-family dyads will receive TAILORED intervention on health decision making

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard of care
Description: Patient-family dyads will receive standard of care in health decision-making
Study: NCT05574543

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGA111
Description: AGA111 is locally administered in an ABC carrier at the intervertebral space during the lumbar interbody fusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGA111
Description: AGA111 is locally administered in an ABC carrier at the intervertebral space during the lumbar interbody fusion.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is locally administered in an ABC carrier at the intervertebral space during the lumbar interbody fusion.
Study: NCT03540121

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video education + adherence contract
Description: Participants will receive standard education along with the home-based video education plus an adherence contract. Following the baseline assessment, access to videos will be provided electronically so that the patient can watch them at home. The videos will be initially viewed in the following order: Video 1: Introduction, Video 2: Medications, Video 3: Your New Life. Approximately one month after transplant, after the video series has been viewed in its entirety, participants will receive an email link inviting participants to reflect on their goals about transplantation and pledging to taking their medications as directed. The contract will be non-enforceable, but it will provide patients with the opportunity to formally commit to a goal of taking the medications as prescribed. At 3 months, and 12 months, the participant will have the opportunity to reflect and modify adherence goals as desired.
Study: NCT03366311

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: holding position
Description: two types of holding positions plus two types of shapes of stylet, with or without epiglottis lift

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: holding position
Description: two types of holding positions plus two types of shapes of stylet, with or without epiglottis lift

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: holding position
Description: two types of holding positions plus two types of shapes of stylet, with or without epiglottis lift
Study: NCT02113722

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Standard of Care
Description: Medical therapy
Study: NCT02063139

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flutiform 50/5 ug (2 puffs bid) pMDI

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluticasone 50 ug (2puffs bid) pMDI

Intervention type: DRUG
Group type: OTHER
Intervention: Beclometasone Autohaler 50 ug (2 puffs bid)
Study: NCT04401137

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Topiramate
Description: Topiramate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate
Description: Topiramate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate
Description: Topiramate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate
Description: Topiramate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate
Description: Topiramate
Study: NCT02798081

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Single arm study
Description: In Step 1 the elderly will participate of eight conventional computer classes which they were spontaneously enrolled. In Step 2, 10 minutes of the next eight classes will be used to practice serious games using virtual reality, using physical interface (keyboard or mouse).
Study: NCT01322321

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACZ885

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT01145391

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Outreach to Patients and Providers
Description: An outreach coordinator raised patient and provider awareness of unmet Blood Pressure goals, arranged Blood Pressure-focused clinic visits, and furnished providers with treatment decision support.
Study: NCT03557372

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Mathematical Model-Adapted Radiation Fractionation Schedule
Description: * Re-irradiation with 35 Gy delivered over 2 weeks, based upon reference dosing of 35 Gy in 10 Fractions over 2 weeks~* Radiation therapy is delivered on Monday-Friday during standard clinic hours in our department. Each treatment may take 20-40 minutes.~* Treatment will be once daily for the first 7 days of treatment and then three-times daily for the last three days of treatment.
Study: NCT02677740

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inhibitory rTMS (1 Hz)
Description: Participants receive rTMS at a rate of 1 Hz, applied with a 70-mm figure-eight TMS coil connected to a stimulator, over the motor cortex hotspot contralateral to the dominant arm for 20 minutes at an intensity of 90% resting motor threshold (RMT) for a total of 600 TMS pulses. The total number of stimuli applied is well within the published safety guidelines for use of rTMS. rTMS is applied outside the scanner, whereas functional connectivity and neurochemistry are measured with MRI and MRS, respectively, at 7 Tesla. The MRI/MRS data are collected right before and immediately after the inhibitory rTMS intervention.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Excitatory rTMS (5 Hz)
Description: Participants receive rTMS at a rate of 5 Hz, applied with a 70-mm figure-eight TMS coil connected to a stimulator, over the motor cortex hotspot contralateral to the dominant arm for 20 minutes at an intensity of 90% RMT for a total of 600 TMS pulses. The total number of stimuli applied is well within the published safety guidelines for use of rTMS. rTMS is applied outside the scanner, whereas functional connectivity and neurochemistry are measured with MRI and MRS, respectively, at 7 Tesla. The MRI/MRS data are collected right before and immediately after the excitatory rTMS intervention.
Study: NCT00244218

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: tetrahydrobiopterin (BH4)
Description: Either placebo or tetrahydrobiopterin (BH4) , 10mg/kg/day will be given for three months. Then the patient will be given three additional months of open label BH4 at the same rate.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tetrahydrobiopterin (BH4)
Description: Either placebo or tetrahydrobiopterin (BH4) , 10mg/kg/day will be given for three months. Then the patient will be given three additional months of open label BH4 at the same rate.
Study: NCT01373554

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 30mig/bid or 60mg/bid P.O

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oltipraz
Description: 30mig/bid or 60mg/bid P.O
Study: NCT00135161

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FDG-PET-based dose escalation using intensity modulated radiation therapy (IMRT).
Description: FDG-PET-based dose escalation using intensity modulated radiation therapy (IMRT).
Study: NCT00415259

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laterally wedged shoe insoles
Description: Full-length 5 degree lateral wedged insoles worn inside the shoes daily for 12 months

Intervention type: DEVICE
Group type: OTHER
Intervention: Control insole group
Description: Flat control insoles worn inside the shoes daily for 12 months
Study: NCT03810794

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: The main acupoints are DU 24, EX-HN 3, DU 20, EX-HN 1, GB 12, HT 7, KI 6, GB39, and then selecting other acupoints according to TCM syndrome. The electric stimulator will be applied to DU 24, GB 12, HT 7, and LR 3 or SP 6 with a disperse-dense wave of 2/50 Hz, 0.5-1.0 mA. There are three sessions per week with each session lasting for 30 min. There will be 12 weeks of treatment for each participant in total.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil
Description: Donepezil 5 mg will be given once daily before bed-time for 12 weeks. After the clinical trial, participants will be given conventional treatment clinically.
Study: NCT04433143

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minocycline hydrochloride capsules were taken orally
Description: Lumenis OneTM, OPT tender system produced by American Medical Science Company; Use four of the filters. Acne filter has a wavelength of 400-600/800-1200nm. Three pulses were used for treatment, with a pulse width of 5.0ms, a pulse delay of 30ns, and an energy density of 15j /cm2. The instrument parameters were selected according to the skin lesion characteristics, age and tolerance.
Study: NCT01116479

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood transfusion
Description: Blood transfusion with packed erythrocytes

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Blood transfusion
Description: Blood transfusion with packed erythrocytes
Study: NCT02483533

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LIPO-202

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT03810794

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Donepezil
Description: Donepezil 5 mg will be given once daily before bed-time for 12 weeks. After the clinical trial, participants will be given conventional treatment clinically.
Study: NCT06737510

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Informational brochure on household emergency preparedness
Description: An informational brochure will be mailed to participants and will cover the following topics: (1) an introduction to why emergency preparedness is important; (2) definition of what a disaster is; (3) family communication plan (including, what is a family communication and evacuation plan, why you should have one, communication plan checklist, family communication card); (4) disaster supplies (including, what types of supplies are needed, how long supplies should last, supply checklist, and storing supplies, including preparing a go bag); and (5) resources (including disaster contact numbers for emergency and non-emergency calls (911 and 311), how to register for emergency notifications (Notify NCY), NYC Emergency Management, as well as a website for additional information on preparedness (NYC.gov/hazards) that includes New York City hurricane evacuation zones .

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Phone-based household emergency preparedness
Description: A phone-based intervention will consist of 15 - 20 minutes discussion covering the following topics: (1) an introduction to why emergency preparedness is important; (2) definition of what a disaster is; (3) family communication plan (including, what is a family communication and evacuation plan, why you should have one, communication plan checklist, including a family communication card); (4) disaster supplies (including, what types of supplies are needed, how long supplies should last, supply checklist, and storing supplies); and (5) resources (including providing NYC Emergency Management website: NYC.gov/hazards, i which includes specific information related to the participants New York City hurricane evacuation zones) .
Study: NCT03125356

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet Soda
Description: Subjects will be asked to consume diet soda three times daily for eight weeks.
Study: NCT02576366

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Voriconazole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampin
Study: NCT01828307

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (MET)
Description: MET is a client-centered, directive method of enhancing intrinsic motivation for change by exploring and resolving ambivalence. In this intervention MET will focus on exercise.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency management
Description: Contingency management is a behavioral treatment that utilizes extrinsic motivation by offering individuals tangible rewards such as prizes for completion of specific target behaviors. The target behavior in this study is exercise.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Aftercare Treatment
Description: Aftercare includes the following topics: substance use, high-risk situations, coping and life skills training, focus groups for depression and anxiety, and AIDS education.
Study: NCT03349567

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Audit-and-feedback
Description: We will monitor the antimicrobial-prescribing of providers in the experimental arm. Our study team will meet with providers in the experimental arm to provide guidance on optimal antimicrobial-prescribing. We will provide personalized feedback to providers in the experimental arm once every quarter.
Study: NCT01828307

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Aftercare Treatment
Description: Aftercare includes the following topics: substance use, high-risk situations, coping and life skills training, focus groups for depression and anxiety, and AIDS education.